[Drug administration to paediatric inpatient]

J E Fontan1, F Mille, F Brion

  • 1Pharmacie et laboratoire de toxicopharmacologie, hôpital Robert-Debré, Assistance-publique-Hôpitaux de Paris, France. jean-eudes.fontan@jvr.ap-hop-paris.fr <jean-eudes.fontan@jvr.ap-hop-paris.fr>

Insights

Pediatric drug administration in France faces significant challenges, with many available medications unsuitable for children. This study highlights issues with drug suitability and administration practices, proposing solutions for improved pediatric patient care.

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Drug Administration

Context:

  • Commercial drugs available in France are often not suitable for pediatric inpatients.
  • Current drug formulations and administration practices pose challenges for nurses caring for children.

Purpose:

  • To identify and quantify difficulties encountered by nurses in administering oral and parenteral medications to pediatric inpatients.
  • To propose solutions for the identified problems in pediatric drug administration.

Summary:

  • A study involving 1,946 observations in 14 hospitals revealed significant issues with pediatric drug administration.
  • Problems included incorrect drug dilutions, inappropriate formulations (e.g., injectable drugs for oral use), incorrect dosages, waste, and off-label use of medications.
  • Specific challenges were noted for injectable drugs, liquid oral forms, capsules, tablets, and bagged medications.

Impact:

  • Confirms the unsuitability of many commercial drugs for pediatric inpatients.
  • Underscores the need for evidence-based recommendations and improved practices in pediatric drug administration.
  • Provides a basis for developing corrective actions to enhance medication safety and efficacy in children.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...